Healthcare
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
MALVERN, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio” or the “Company”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, announced that the Board of Directors (the “Board”) has appointed Heather Getz as Chief Executive Officer and Director, effective today. “As TELA Bio enters its next phase of growth and commercial execution, the Board is pleased to welcome Heather as our next Chief Executive Officer,” said
About this update from Tela Bio, Inc.
MALVERN, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio" or the "Company"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, announced that the Board of Directors (the "Board") has appointed Heather Getz as Chief Executive Officer and Director, effective today. "As TELA Bio enters its next phase of growth and commercial execution, the Board is pleased to welcome Heather as our next Chief Executive Officer," said Joseph Capper, Chairman of the Board of TELA Bio. "Heather brings a proven track record of driving operational excellence, leading organizations through complex business and financial transformations, and creating long-term value. We are confident that under Heather's leadership, TELA Bio will build on its strong foundation, expand its impact for patients and surgeons, and deliver value for our shareholders and employees." "On behalf of the Board, I also want to extend our sincere gratitude to Tony Koblish for his vision, leadership, and entrepreneurial spirit in founding TELA Bio. Tony's commitment to innovation led to the development of OviTex™ and helped establish TELA Bio as a leader in soft tissue reconstruction. We are deeply appreciative of his many contributions and wish him continued success in his future endeavors." Ms. Getz joins TELA Bio having most recently served as Executive Vice President and Chief Financial and Operations Officer at Butterfly Network, Inc., (NYSE: BFLY). While at Butterfly, she made transformative changes in its strategy, capital allocation, cash runway and investor relations while building a performance culture. Prior to Butterfly, Heather was the Executive Vice President and Chief Financial and Administrative Officer at BioTelemetry, Inc., a leading remote medical technology company, where during her tenure, BioTelemetry's market capitalization grew from $50 million to $2.8 billion, prior to being acquired by Philips Healthcare in 2021. Heather previously held other executive positions at Healthy io, VIASYS Healthcare Inc., and Alita Pharmaceuticals, Inc. "I am honored to join TELA Bio at such an exciting time in the Company's evolution," said Heather Getz, newly appointed Chief Executive Officer of TELA Bio. "TELA Bio has built a differentiated portfolio, a strong commercial foundation, and a clear commitment to imp...